Log in

Group activity

    • Abdullah
      The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH). In the key northeastern region of Adamawa...